Dofetilide Initiation and Implications of Deviation From the Standard Protocol – A Real World Experience

BACKGROUND: Manufacturer/federal drug administration (FDA) recommends inpatient initiation of dofetilide with the manufacturer providing an initiation algorithm. The outcomes of algorithm deviation have not been reported outside of clinical trials. OBJECTIVE: We sought to perform a chart review of a...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Atr Fibrillation
Hlavní autoři: Dar, Tawseef, Murtaza, Ghulam, Yarlagadda, Bharath, Madoukh, Bader, Bravin, Lesley, Vuddanda, Venkat, Parikh, Valay, Reddy, Madhu, Lakkireddy, Dhanunjaya
Médium: Artigo
Jazyk:Inglês
Vydáno: Cardiofront, Inc 2019
Témata:
Original Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7237080/
https://ncbi.nlm.nih.gov/pubmed/32435348
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4022/jafib.2265
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky